Key Transactions

Serum-Institute-Life-Sciences-Tata-Capital-Healthcare-Fund

M&A

INR 25 bn

FY26

Exclusive Financial Advisor to Serum Institute & Tata Capital

Ambit acted as Exclusive Financial Advisor to Serum Institute & Tata Capital on their ~25bn divestment in Biocon Biologics

Exclusive Financial Advisor to Serum Institute & Tata Capital

Ambit acted as Exclusive Financial Advisor to Serum Institute & Tata Capital on their ~25bn divestment in Biocon Biologics

CVC Capital

ECM

INR 5.5 bn

FY26

Sale of PE Investor's stake

Ambit Successfully Executes ~INR 550 Cr Block Deal for CVC in HCG

Sale of PE Investor's stake

Ambit Successfully Executes ~INR 550 Cr Block Deal for CVC in HCG

Investors

ECM

INR 1 bn

FY26

Sale of Investor's stake

Ambit Successfully Executes ~INR 100 Cr Block Deal in Senores

Sale of Investor's stake

Ambit Successfully Executes ~INR 100 Cr Block Deal in Senores

bank-of-maharashtra

ECM

INR 26 bn

FY26

Broker to Government of India for divestment of c.60% paid by equity capital in Bank of Maharashtra

Ambit successfully acted as Broker for the Offer for Sale by the Government of India (“GoI”) for a c.6.0% stake in Bank of Maharashtra. The GoI sold c. 46.1 crore equity shares of the Bank (c.6.0% of the total paid up equity shares of the Bank – c.5.0% as base offer & c. 1.0% as oversubscription option) for a total consideration of over c. INR 2,600 crore.

Broker to Government of India for divestment of c.60% paid by equity capital in Bank of Maharashtra

Ambit successfully acted as Broker for the Offer for Sale by the Government of India (“GoI”) for a c.6.0% stake in Bank of Maharashtra. The GoI sold c. 46.1 crore equity shares of the Bank (c.6.0% of the total paid up equity shares of the Bank – c.5.0% as base offer & c. 1.0% as oversubscription option) for a total consideration of over c. INR 2,600 crore.

ingrid

ECM

INR 15 bn

FY26

Book Running Lead Manager for Institutional Placement of IndiGrid Infrastructure Trust

Ambit acted as the BRLM to INR 15 bn Institutional Placement of IndiGrid Infrastructure Trust. The transaction witnessed participation from Tier 1 MFs and FIIs, with Ambit capturing c. 38% share of the investor allocation in a multi bank syndicate.

Book Running Lead Manager for Institutional Placement of IndiGrid Infrastructure Trust

Ambit acted as the BRLM to INR 15 bn Institutional Placement of IndiGrid Infrastructure Trust. The transaction witnessed participation from Tier 1 MFs and FIIs, with Ambit capturing c. 38% share of the investor allocation in a multi bank syndicate.

joe-and-the-juice

Capital Raise

NA

FY26

Ambit acts as exclusive advisor to Joe & the Juice for India Foray

Ambit acted as the exclusive advisor to Joe & the Juice on its strategic partnership with Aditya Birla New Age Hospitality for its India entry

Ambit acts as exclusive advisor to Joe & the Juice for India Foray

Ambit acted as the exclusive advisor to Joe & the Juice on its strategic partnership with Aditya Birla New Age Hospitality for its India entry

cppib

M&A

INR 27 bn

FY25

Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)

Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited

Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)

Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited

orbicular-pharmaceutical-technologies-pvt.-ltd.

Capital Raise

USD 20 mn

FY25

Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise

Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund

Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise

Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund

cube-highways-and-infrastructure-III-pte-ltd.

M&A

INR 28.4 bn

FY25

Sale of a portfolio of 7 road assets to Cube InvIT by Cube Highways and Infrastructure III Pte Ltd.

Ambit acted as an exclusive financial advisor to Cube Highways and Infrastructure III Pte Ltd. on their 100% stake sale in seven road assets to Cube Highways Trust (“Cube InvIT”).

Sale of a portfolio of 7 road assets to Cube InvIT by Cube Highways and Infrastructure III Pte Ltd.

Ambit acted as an exclusive financial advisor to Cube Highways and Infrastructure III Pte Ltd. on their 100% stake sale in seven road assets to Cube Highways Trust (“Cube InvIT”).